Skip to main content
OpenTrials
Completed

NCT Number: NCT03633240

Emergency Room Visits and Older Patients (ER2)

Today's population is living longer than prior generations. Senior patients, defined as 65 years or older, are therefore increasing in number, and representing a larger number of hospitalized patients. Thus, assessing and addressing the needs of the growing number of older ER users is essential. The overall objective of the study is to examine the feasibility and the epidemiology of two screening tools ("Programme de Recherche sur l'Intégration des Services pour le Maintien de l'Autonomie" (PRISMA-7) and Emergency Room Evaluation and recommendations (ER2)) used in the Emergency Room of Jewish General Hospital to screen older patients (i.e.; ≥65 years) at risk of adverse health events. A prospective observational cohort design will be used for the study's two phases; phase 1- assessment and phase 2- assessment as well as recommendations.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Emergencies Disease Attributes Length of Stay Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

65 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Jewish General Hospital

Montreal, Quebec, H3T 1E2, Canada

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age ≥ 65 years.
  • Unplanned ER visits.

Exclusion criteria

  • Death within the 24 hours of first visiting ER.
  • Palliative care due to ER visit.

Treatment and study plan

ER assessment

Other

To measure the effects of recommendations of ER2, the investigators will use ER users who will have an ER2 assessment without any recommendations as the referent group the older. This choice is possible because ER2 will be integrated into ER care in two steps:

The first step will be limited to its assessment component in order to learn how to use the tool.

The second step will be to follow the recommendations provided after the assessment.

Participants will follow-up during their hospitalization via a review of their chart. They will be censored when they will be discharged from the JGH or when the duration of hospitalization will exceed 31 days.

Primary outcomes

  1. Feasibility of using both tools in the ER

    Time frame: 1 day

    Percentage of participants with complete filed tools (older patients with tools filed / (older patients visiting the ER) x 100) will be calculated.

  2. Prevalence of tools filed

    Time frame: 1 day

    Prevalence will be calculated for PRISMA-7, ER2 and pooled tools respectively.

Secondary outcomes

  1. Feasibility of tools

    Time frame: 1 day

    Estimation of quality of filling using the percentage of items filled in for participants with an incomplete tool.

  2. Length of stay

    Time frame: 1 day

    The LHS will be calculated using the administrative registry of the JGH and will correspond to the delay in days between the first day of admission to ED and the last day of hospitalization in the acute ward(s).

  3. Acute medical events

    Time frame: 1 day

    Acute medical events occurring during the period of the ER visit and admission to the medical or surgery ward (acute organ failure, nosocomial infection, fall or death)

Sponsors and collaborators

Lead sponsor

Jewish General Hospital

Other

Registry information

Official study title

Emergency Room Visits and Older Patients: Assessment of Jewish General Hospital Program Screening Frail Users

Acronym: ER2

Important dates

Study start
2017
Primary completion
2021
Study completion
2024
First posted
Aug 16, 2018
Registry last updated
Jul 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.